Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 18 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
ALLOPHARM.BE from Waremme, company number BE0474254378, closed financial year 2025 with a result of € 1,730 after tax. For that financial year ALLOPHARM.BE recorded a gross margin of € 5,901 and equity of € -33,076. Compared with financial year 2024, the result moved from € 7,143 to € 1,730. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ -33,076
▲ € 1,730 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1,730
▼ 76% vs 2024
Profit after tax over the fiscal year.
€ 9,386
▲ 14% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -306,938.
People and assets in 2025
€ 2,275
▲ 4% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,202
▼ 32% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -109 | € 10,627 | € 9,632 | € 5,901 | ▼ 39% |
| Profit after taxes | € -2,019 | € 8,587 | € 7,143 | € 1,730 | ▼ 76% |
| Equity | € -50,536 | € -41,949 | € -34,806 | € -33,076 | ▲ € 1,730 |
| Total debts | € 110,058 | € 93,895 | € 65,335 | € 53,056 | ▼ 19% |
| Cash | € 42,999 | € 23,894 | € 8,268 | € 9,386 | ▲ 14% |
| Retained profit | € -324,398 | € -315,811 | € -308,668 | € -306,938 | ▲ € 1,730 |
| Balance sheet total | € 59,522 | € 51,946 | € 30,529 | € 19,980 | ▼ 35% |
Key figures of ALLOPHARM.BE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ALLOPHARM.BE?
What happened at ALLOPHARM.BE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Réginald DE MEEUS stepped down as director. NBB
- Marie-Gabrielle VAN DER STRAETEN stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 1,730 (▼ 76% vs 2024). Source: NBB ↗
- Réginald DE MEEUS became a director. NBB
- Marie-Gabrielle VAN DER STRAETEN became a director. NBB
- New establishment in Waremme. KBO
- Start of the company according to the CBE. KBO
In short
From € 2,019 loss in 2022 to € 1,730 profit in 2025.
Best year ever: 2023, with € 8,587 profit.
Management
Directors
According to the 2025 annual accounts
Réginald DE MEEUS
Managing director
since 2025 · until 2030
Marie-Gabrielle VAN DER STRAETEN
Director
since 2025 · until 2030
Establishments
Establishment units
Physical locations of this company
Rue de Huy 51
4300 Waremme
Rue de Huy 51 box 7
4300 Waremme
Active since 23 January 2002
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0474.254.378
- VAT number
- BE 0474.254.378
- Registered office
- Rue de Huy 51, 4300 Waremme
- Names & denominations
- ALLOPHARM.BE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 6 March 2001
- Peppol
- Active · Active since 2 Jun 2025
- Activities · NACE
Vervaardiging van parfums en toiletartikelen
Vervaardiging van parfums en cosmetische artikelen